Global Oncology Biosimilars Market Research Report 2016 Chapter 1 Oncology Biosimilars Market Overview 1.1 Product Overview and Scope of Oncology Biosimilars 1.2 Oncology Biosimilars Market Segmentation by Type 1.2.1 Global Production Market Share of Oncology Biosimilars by Type in 2015 1.2.1 Type I 1.2.2 Type II 1.2.3 Type III 1.3 Oncology Biosimilars Market Segmentation by Application 1.3.1 Oncology Biosimilars Consumption Market Share by Application in 2015 1.3.2 Application I 1.3.3 Application II 1.3.4 Application III 1.4 Oncology Biosimilars Market Segmentation by Regions 1.4.1 North America 1.4.2 China 1.4.3 Europe 1.4.4 Southeast Asia 1.4.5 Japan 1.4.6 India 1.5 Global Market Size (Value) of Oncology Biosimilars (2011-2021) Chapter 2 Global Economic Impact on Oncology Biosimilars Industry 2.1 Global Macroeconomic Environment Analysis 2.1.1 Global Macroeconomic Analysis 2.1.2 Global Macroeconomic Environment Development Trend 2.2 Global Macroeconomic Environment Analysis by Regions 2.3 Effects to Oncology Biosimilars Industry Chapter 3 Global Oncology Biosimilars Market Competition by Manufacturers 3.1 Global Oncology Biosimilars Production and Share by Manufacturers (2015 and 2016) 3.2 Global Oncology Biosimilars Revenue and Share by Manufacturers (2015 and 2016) 3.3 Global Oncology Biosimilars Average Price by Manufacturers (2015 and 2016) 3.4 Manufacturers Oncology Biosimilars Manufacturing Base Distribution, Sales Area and Product Type 3.5 Oncology Biosimilars Market Competitive Situation and Trends 3.5.1 Oncology Biosimilars Market Concentration Rate 3.5.2 Oncology Biosimilars Market Share of Top 3 and Top 5 Manufacturers 3.5.3 Mergers & Acquisitions, Expansion Chapter 4 Global Oncology Biosimilars Production, Revenue (Value) by Region (2011-2016) 4.1 Global Oncology Biosimilars Production by Region (2011-2016) 4.2 Global Oncology Biosimilars Production Market Share by Region (2011-2016) 4.3 Global Oncology Biosimilars Revenue (Value) and Market Share by Region (2011-2016) 4.4 Global Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016) 4.5 North America Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016) 4.6 Europe Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016) 4.7 China Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016) 4.8 Japan Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016) 4.9 Southeast Asia Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016) 4.10 India Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016) Chapter 5 Global Oncology Biosimilars Supply (Production), Consumption, Export, Import by Regions (2011-2016) 5.1 Global Oncology Biosimilars Consumption by Regions (2011-2016) 5.2 North America Oncology Biosimilars Production, Consumption, Export, Import by Regions (2011-2016) 5.3 Europe Oncology Biosimilars Production, Consumption, Export, Import by Regions (2011-2016) 5.4 China Oncology Biosimilars Production, Consumption, Export, Import by Regions (2011-2016) 5.5 Japan Oncology Biosimilars Production, Consumption, Export, Import by Regions (2011-2016) 5.6 Southeast Asia Oncology Biosimilars Production, Consumption, Export, Import by Regions (2011-2016) 5.7 India Oncology Biosimilars Production, Consumption, Export, Import by Regions (2011-2016) Chapter 6 Global Oncology Biosimilars Production, Revenue (Value), Price Trend by Type 6.1 Global Oncology Biosimilars Production and Market Share by Type (2011-2016) 6.2 Global Oncology Biosimilars Revenue and Market Share by Type (2011-2016) 6.3 Global Oncology Biosimilars Price by Type (2011-2016) 6.4 Global Oncology Biosimilars Production Growth by Type (2011-2016) Chapter 7 Global Oncology Biosimilars Market Analysis by Application 7.1 Global Oncology Biosimilars Consumption and Market Share by Application (2011-2016) 7.2 Global Oncology Biosimilars Consumption Growth Rate by Application (2011-2016) 7.3 Market Drivers and Opportunities 7.3.1 Potential Applications 7.3.2 Emerging Markets/Countries Chapter 8 Global Oncology Biosimilars Manufacturers Analysis 8.1 Biocon 8.1.1 Company Basic Information, Manufacturing Base and Competitors 8.1.2 Product Type, Application and Specification 8.1.3 Sales, Revenue, Price and Gross Margin (2011-2016) 8.1.4 Business Overview 8.2 Amgen 8.2.1 Company Basic Information, Manufacturing Base and Competitors 8.2.2 Product Type, Application and Specification 8.2.3 Sales, Revenue, Price and Gross Margin (2011-2016) 8.2.4 Business Overview 8.3 Celltrion 8.3.1 Company Basic Information, Manufacturing Base and Competitors 8.3.2 Product Type, Application and Specification 8.3.3 Sales, Revenue, Price and Gross Margin (2011-2016) 8.3.4 Business Overview 8.4 Hospira 8.4.1 Company Basic Information, Manufacturing Base and Competitors 8.4.2 Product Type, Application and Specification 8.4.3 Sales, Revenue, Price and Gross Margin (2011-2016) 8.4.4 Business Overview 8.5 Biogen 8.5.1 Company Basic Information, Manufacturing Base and Competitors 8.5.2 Product Type, Application and Specification 8.5.3 Sales, Revenue, Price and Gross Margin (2011-2016) 8.5.4 Business Overview 8.6 Mylan 8.6.1 Company Basic Information, Manufacturing Base and Competitors 8.6.2 Product Type, Application and Specification 8.6.3 Sales, Revenue, Price and Gross Margin (2011-2016) 8.6.4 Business Overview 8.7 Pfizer 8.7.1 Company Basic Information, Manufacturing Base and Competitors 8.7.2 Product Type, Application and Specification 8.7.3 Sales, Revenue, Price and Gross Margin (2011-2016) 8.7.4 Business Overview 8.8 Dr. Reddy'sLaboratories 8.8.1 Company Basic Information, Manufacturing Base and Competitors 8.8.2 Product Type, Application and Specification 8.8.3 Sales, Revenue, Price and Gross Margin (2011-2016) 8.8.4 Business Overview 8.9 Roche 8.9.1 Company Basic Information, Manufacturing Base and Competitors 8.9.2 Product Type, Application and Specification 8.9.3 Sales, Revenue, Price and Gross Margin (2011-2016) 8.9.4 Business Overview 8.10 GlaxoSmithKline(GSK) 8.10.1 Company Basic Information, Manufacturing Base and Competitors 8.10.2 Product Type, Application and Specification 8.10.3 Sales, Revenue, Price and Gross Margin (2011-2016) 8.10.4 Business Overview 8.11 Merck 8.12 Sanofiand 8.13 Sandoz. Chapter 9 Oncology Biosimilars Manufacturing Cost Analysis 9.1 Oncology Biosimilars Key Raw Materials Analysis 9.1.1 Key Raw Materials 9.1.2 Price Trend of Key Raw Materials 9.1.3 Key Suppliers of Raw Materials 9.1.4 Market Concentration Rate of Raw Materials 9.2 Proportion of Manufacturing Cost Structure 9.2.1 Raw Materials 9.2.2 Labor Cost 9.2.3 Manufacturing Expenses 9.3 Manufacturing Process Analysis of Oncology Biosimilars Chapter 10 Industrial Chain, Sourcing Strategy and Downstream Buyers 10.1 Oncology Biosimilars Industrial Chain Analysis 10.2 Upstream Raw Materials Sourcing 10.3 Raw Materials Sources of Oncology Biosimilars Major Manufacturers in 2015 10.4 Downstream Buyers Chapter 11 Analysis of Investment Strategy 11.1 Industry Development Characters 11.1.1 Periodicity of the industry 11.1.2 Regional traits of the industry 11.1.3 Upstream and downstream of Oncology Biosimilars industry 11.1.4 Operational mode of the industry 11.2 Analysis of Investment Situation of Oncology Biosimilars Industry 11.2.1 Development Pattern 11.2.2 Entry Barrier 11.2.3 Industrial SWOT Analysis 11.2.4 Analysis of Industrial Five Forces Mode 11.3 Analysis of Development Trend Chapter 12 Marketing Strategy Analysis, Distributors/Traders 12.1 Marketing Channel 12.1.1 Direct Marketing 12.1.2 Indirect Marketing 12.1.3 Marketing Channel Development Trend 12.2 Market Positioning 12.2.1 Pricing Strategy 12.2.2 Brand Strategy 12.2.3 Target Client 12.3 Distributors/Traders List Chapter 13 Market Effect Factors Alysis 13.1 Technology Progress/Risk 13.1.1 Substitutes Threat 13.1.2 Technology Progress in Related Industry 13.2 Consumer Needs/Customer Preference Change 13.3 Economic/Political Environmental Change Chapter 14 Global Oncology Biosimilars Market Forecast (2016-2021) 14.1 Global Oncology Biosimilars Production, Revenue Forecast (2016-2021) 14.2 Global Oncology Biosimilars Production, Consumption Forecast by Regions (2016-2021) 14.3 Global Oncology Biosimilars Production Forecast by Type (2016-2021) 14.4 Global Oncology Biosimilars Consumption Forecast by Application (2016-2021) 14.5 Oncology Biosimilars Price Forecast (2016-2021) Chapter 15 Research Findings and Conclusion Chapter 16 Appendix Author List Disclosure Section Research Methodology Data Source China Disclaimer

Table Product Overview and Scope of Oncology Biosimilars Table Major Manufacturers of Type I Table Major Manufacturers of Type II Table Major Manufacturers of Type III Table Oncology Biosimilars Consumption Market Share by Application in 2015 Table Global Oncology Biosimilars Capacity of Key Manufacturers (2015 and 2016) Table Global Oncology Biosimilars Capacity Market Share by Manufacturers (2015 and 2016) Table Global Oncology Biosimilars Production of Key Manufacturers (2015 and 2016) Table Global Oncology Biosimilars Production Share by Manufacturers (2015 and 2016) Table Global Oncology Biosimilars Revenue (Million USD) by Manufacturers (2015 and 2016) Table Global Oncology Biosimilars Revenue Share by Manufacturers (2015 and 2016) Table 2015 Global Oncology Biosimilars Revenue Share by Manufacturers Table 2016 Global Oncology Biosimilars Revenue Share by Manufacturers Table Global Market Oncology Biosimilars Average Price of Key Manufacturers (2015 and 2016) Table Manufacturers Oncology Biosimilars Manufacturing Base Distribution and Sales Area Table Manufacturers Oncology Biosimilars Product Type Table Global Oncology Biosimilars Capacity by Regions (2011-2016) Table Global Oncology Biosimilars Production by Regions (2011-2016) Table Global Oncology Biosimilars Revenue by Regions (2011-2016) Table Global Oncology Biosimilars Revenue Market Share by Regions (2011-2016) Table 2015 Global Oncology Biosimilars Revenue Market Share by Regions Table Global Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016) Table North America Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016) Table Europe Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016) Table China Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016) Table Japan Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016) Table Southeast Asia Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016) Table India Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016) Table Global Oncology Biosimilars Consumption Market by Regions (2011-2016) Table Global Oncology Biosimilars Consumption Market Share by Regions (2011-2016) Table North America Oncology Biosimilars Production, Consumption, Import & Export (2011-2016) Table Europe Oncology Biosimilars Production, Consumption, Import & Export (2011-2016) Table China Oncology Biosimilars Production, Consumption, Import & Export (2011-2016) Table Japan Oncology Biosimilars Production, Consumption, Import & Export (2011-2016) Table Southeast Asia Oncology Biosimilars Production, Consumption, Import & Export (2011-2016) Table India Oncology Biosimilars Production, Consumption, Import & Export (2011-2016) Table Global Oncology Biosimilars Production by Type (2011-2016) Table Global Oncology Biosimilars Production Share by Type (2011-2016) Table Global Oncology Biosimilars Revenue by Type (2011-2016) Table Global Oncology Biosimilars Revenue Share by Type (2011-2016) Table Global Oncology Biosimilars Price by Type (2011-2016) Table Global Oncology Biosimilars Consumption by Application (2011-2016) Table Global Oncology Biosimilars Consumption Market Share by Application (2011-2016) Table Global Oncology Biosimilars Consumption Growth Rate by Application (2011-2016) Table Biocon Basic Information List Table Biocon Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016) Figure Biocon Oncology Biosimilars Global Market Share (2011-2016) Table Amgen Basic Information List Table Amgen Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016) Figure Amgen Oncology Biosimilars Global Market Share (2011-2016) Table Celltrion Basic Information List Table Celltrion Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016) Figure Celltrion Oncology Biosimilars Global Market Share (2011-2016) Table Hospira Basic Information List Table Hospira Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016) Figure Hospira Oncology Biosimilars Global Market Share (2011-2016) Table Biogen Basic Information List Table Biogen Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016) Figure Biogen Oncology Biosimilars Global Market Share (2011-2016) Table Mylan Basic Information List Table Mylan Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016) Figure Mylan Oncology Biosimilars Global Market Share (2011-2016) Table Pfizer Basic Information List Table Pfizer Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016) Figure Pfizer Oncology Biosimilars Global Market Share (2011-2016) Table Dr. Reddy’s Laboratories Basic Information List Table Dr. Reddy’s Laboratories Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016) Figure Dr. Reddy’s Laboratories Oncology Biosimilars Global Market Share (2011-2016) Table Roche Basic Information List Table Roche Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016) Figure Roche Oncology Biosimilars Global Market Share (2011-2016) Table GlaxoSmithKline (GSK) Basic Information List Table GlaxoSmithKline (GSK) Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016) Figure GlaxoSmithKline (GSK) Oncology Biosimilars Global Market Share (2011-2016) Table Merck Basic Information List Table Merck Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016) Figure Merck Oncology Biosimilars Global Market Share (2011-2016) Table Sanofi Basic Information List Table Sanofi Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016) Figure Sanofi Oncology Biosimilars Global Market Share (2011-2016) Table Sandoz Basic Information List Table Sandoz Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016) Figure Sandoz Oncology Biosimilars Global Market Share (2011-2016) Table Production Base and Market Concentration Rate of Raw Material Table Key Suppliers of Raw Materials Table Raw Materials Sources of Oncology Biosimilars Major Manufacturers in 2015 Table Major Buyers of Oncology Biosimilars Table Distributors/Traders List Table Four basic brand strategies Table Industrial SWOT Analysis Table Global Oncology Biosimilars Production Forecast by Regions (2016-2021) Table Global Oncology Biosimilars Consumption Forecast by Regions (2016-2021) Table Global Oncology Biosimilars Production Forecast by Type (2016-2021) Table Global Oncology Biosimilars Consumption Forecast by Application (2016-2021) Figure Picture of Oncology Biosimilars Figure Global Production Market Share of Oncology Biosimilars by Type in 2015 Figure Application of Oncology Biosimilars Figure North America Oncology Biosimilars Revenue (Million USD) and Growth Rate (2011-2021) Figure Europe Oncology Biosimilars Revenue (Million USD) and Growth Rate (2011-2021) Figure China Oncology Biosimilars Revenue (Million USD) and Growth Rate (2011-2021) Figure Japan Oncology Biosimilars Revenue (Million USD) and Growth Rate (2011-2021) Figure Southeast Asia Oncology Biosimilars Revenue (Million USD) and Growth Rate (2011-2021) Figure India Oncology Biosimilars Revenue (Million USD) and Growth Rate (2011-2021) Figure Global Oncology Biosimilars Revenue (Million UDS) and Growth Rate (2011-2021) Figure Global Oncology Biosimilars Capacity of Key Manufacturers in 2015 Figure Global Oncology Biosimilars Capacity of Key Manufacturers in 2016 Figure 2015 Oncology Biosimilars Production Share by Manufacturers Figure 2016 Oncology Biosimilars Production Share by Manufacturers Figure Global Market Oncology Biosimilars Average Price of Key Manufacturers in 2015 Figure Oncology Biosimilars Market Share of Top 3 Manufacturers Figure Oncology Biosimilars Market Share of Top 5 Manufacturers Figure Global Oncology Biosimilars Capacity Market Share by Regions (2011-2016) Figure Global Oncology Biosimilars Capacity Market Share by Regions (2011-2016) Figure 2015 Global Oncology Biosimilars Capacity Market Share by Regions Figure Global Oncology Biosimilars Production and Market Share by Regions (2011-2016) Figure Global Oncology Biosimilars Production Market Share by Regions (2011-2016) Figure 2015 Global Oncology Biosimilars Production Market Share by Regions Figure Global Oncology Biosimilars Consumption Market Share by Regions (2011-2016) Figure 2015 Global Oncology Biosimilars Consumption Market Share by Regions Figure Production Market Share of Oncology Biosimilars by Type (2011-2016) Figure 2015 Production Market Share of Oncology Biosimilars by Type Figure Production Revenue Share of Oncology Biosimilars by Type (2011-2016) Figure 2015 Revenue Market Share of Oncology Biosimilars by Type Figure Global Oncology Biosimilars Production Growth by Type (2011-2016) Figure Global Oncology Biosimilars Consumption Market Share by Application in 2015 Figure Global Oncology Biosimilars Consumption Growth Rate by Application (2011-2016)

Biocon Amgen Celltrion Hospira Biogen Mylan Pfizer Dr. Reddy's Laboratories Roche GlaxoSmithKline (GSK) Merck Sanofi and Sandoz.